← Evidence library

BIB_249

NCT06896552 — "Single-Center Trial on Ketogenic Diet and Immunotherapy" (clinicaltrials.gov/study/NCT06896552). 2024-registered trial evaluating ketogenic diet + immunotherapy combination in cancer patients. Stage of disease eligible: advanced/metastatic (immunotherapy indication implies Stage III/IV). Not Stage I/II adjuvant. Recruiting; results not yet posted. Cross-link: NCT05119010 = Pilot of Nivolumab + Ipilimumab + Ketogenic Diet (similar advanced-disease design). No Stage I/II adjuvant melanoma keto RCT exists as of 2026-05. Reinforces brief's 2026-05-08 anti-keto-at-IB position. [Tasks…

Evidence grade

N/A

Tier

1 (clinical-trial re

Cited by tasks

10, 16, 17

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_249/findings.md (research corpus). This page is a short context summary — not individualised medical advice.